Here are four news updates on key gastroenterology and endoscopy companies.
The FDA has granted Medtronic's Verify Evaluation System approval for three- to seven-day basic evaluations designed to expedite the potential for long-term restoration of bowel or bladder function, according to a Med Device Online report.
EndoChoice shares dropped 7.61 percent during the past week and decreased by 23.9 percent in the last four weeks, according to a News Watch International report.
Olympus released a new version of its SONICBEAT surgical device, which will enhance the entire Olympus THUNDERBEAT portfolio.
Lumicell, a company focused on image-guided cancer surgery, received approval from the FDA to launch a feasibility study in gastrointestinal cancers.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Anuja Vaidya at avaidya@beckershealthcare.com.
More GI/endoscopy news:
GI physician leader to know: Dr. David Forcione of Massachusetts General Hospital
Dr. H. Whitney Jennings joins Harbin Clinic: 4 quick facts
Leading medical journal publishes results on IBSREST study — 5 notes